Correvio Pharma Corp. Business Combination, Consideration Transferred
Correvio Pharma Corp. had Business Combination, Consideration Transferred of $75.90 million as of 2020-03-16, per its 20-F filed 2020-04-30.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2020-04-30
| Period end | Business Combination, Consideration Transferred | Business Combination, Consideration Transferred 11 month | Business Combination, Consideration Transferred 12 month |
|---|---|---|---|
| 2020-03-16 | $75.90M 20-F · filed 2020-04-30 | ||
| 2013-12-31 | $21.58M 40-F/A · filed 2014-04-30 | ||
| 2013-11-18 | $21.58M 40-F · filed 2015-03-27 |